Myeloperoxidase (MPO) is a vital enzyme in the immune system, with the potential to revolutionise antiseptics and cancer therapy.

Professor Robert C. Allen has developed MPO-based antiseptics effective in blood which are systemically safe, while also demonstrating selective anticancer properties. Together with Jackson T. Stephens, the work overcomes obstacles to bring these therapies into widespread use, offering promising solutions for infection control and bladder cancer treatment.

Read more in Research Features

Read the original research: doi.org/10.1158/1538-7445.AM2024-2029